What is a clinical trial?
A clinical trial is a supervised study testing whether a new treatment — or a new combination or timing of existing ones — works better than the current standard. Every standard cancer drug you have ever heard of earned its approval through trials. Joining one is not a last resort; for some patients it is the only route to tomorrow’s drug today, often free of cost.
The phases, simply
- Phase 1 — first human testing, small groups: finds the safe dose.
- Phase 2 — does it work in this cancer? Dozens to a few hundred patients.
- Phase 3 — head-to-head against the current standard, often randomised, hundreds to thousands.
“Randomised” means a computer assigns you to the new arm or the standard arm — and in cancer trials the comparison arm receives the standard of care, not a sugar pill. Placebo-only arms in cancer treatment trials are rare and only used where no standard exists.
Three myths, corrected
- “I’d be a guinea pig.” Trials are the most closely monitored care in oncology — extra scans, extra reviews, oversight boards.
- “Trials are only for when everything failed.” Many trials specifically recruit newly diagnosed patients. Eligibility windows close as you receive more treatment — which is why asking early matters.
- “My doctor would have mentioned it.” Doctors cannot track every trial. Asking “is there a trial that fits my profile?” is normal and expected.
How to actually find one
- Ask your oncologist and, if available, a molecular tumour board — trials increasingly recruit by mutation, not just cancer type, so bring your genomic report.
- Search clinicaltrials.gov by your cancer type and country; India’s registry is CTRI (ctri.nic.in).
- Check eligibility with the trial team directly — coordinators answer patient emails every day.
Have a genomic report and want to know what it might unlock? Open a ticket — mapping findings to matched-therapy evidence is what our analysis does.